https://de.marketscreener.com/kurs/aktie/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-Pharmaceutical-Cerevance-startet-mit-neuer-Technologie-Medikamentenportfolio-und-36-Mill-23494260/?utm_source=telegram&utm_medium=social&utm_campaign=share